816 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B N/A
Article Searches
Pharma ETFs Soaring on Solid Q2 Earnings http://www.zacks.com/stock/news/226660/pharma-etfs-soaring-on-solid-q2-earnings?cid=CS-ZC-FT-226660 Aug 03, 2016 - Pharma ETFs are in focus in the days ahead on impressive Q2 results.
Pfizer (PFE) Tops on Q2 Earnings, Revenues, Maintains View http://www.zacks.com/stock/news/226287/pfizer-pfe-tops-on-q2-earnings-revenues-maintains-view?cid=CS-ZC-FT-226287 Aug 02, 2016 - Pfizer (PFE) surpassed earnings and revenue estimates again in the second quarter.
AbbVie (ABBV) Beats on 2Q Earnings, Revenues, Ups View http://www.zacks.com/stock/news/225863/abbvie-abbv-beats-on-2q-earnings-revenues-ups-view?cid=CS-ZC-FT-225863 Jul 29, 2016 - AbbVie (ABBV) raised its 2016 outlook following its Q2 earnings and revenue beat.
Merck (MRK) Updates Outlook Following Q2 Earnings Beat http://www.zacks.com/stock/news/225848/merck-mrk-updates-outlook-following-q2-earnings-beat?cid=CS-ZC-FT-225848 Jul 29, 2016 - Merck (MRK) surpassed Q2 earnings expectations by a penny while revenues were in-line with estimates.
Bristol-Myers Squibb (BMY) Giovanni Caforio on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3992921-bristol-myers-squibb-bmy-giovanni-caforio-q2-2016-results-earnings-call-transcript?source=feed_sector_healthcare Jul 28, 2016 - Bristol-Myers Squibb Co. (NYSE:BMY)Q2 2016 Earnings CallJuly 28, 2016 10:30 am ETExecutivesJohn E. Elicker - Senior VP-Public Affairs & Investor RelationsGiovanni Caforio - Chief Executive Officer & D
Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook http://www.zacks.com/stock/news/225602/bristol-myers-bmy-beats-on-q2-earnings-lifts-outlook?cid=CS-ZC-FT-225602 Jul 28, 2016 - Bristol-Myers' (BMY) delivered better-than-expected second-quarter 2016 earnings and revenues; it raised the 2016 earnings outlook yet again.
McKesson (MCK) Beats on Q1 Earnings, Maintains Guidance http://www.zacks.com/stock/news/225578/mckesson-mck-beats-on-q1-earnings-maintains-guidance?cid=CS-ZC-FT-225578 Jul 28, 2016 - McKesson Corporation (MCK) reported first-quarter fiscal 2017 (ended Jun 30, 2016) earnings of $3.50 per share, above the Zacks Consensus Estimate of $3.35.
Bristol-Myers (BMY) Tops Q2 Earnings and Revenues http://www.zacks.com/stock/news/225468/bristol-myers-bmy-tops-q2-earnings-and-revenues?cid=CS-ZC-FT-225468 Jul 28, 2016 - Bristol-Myers beat on second-quarter 2016 earnings and revenue estimates.
Nivalis (NVLS): Can the Stock Surprise This Earnings Season? http://www.zacks.com/stock/news/225411/nivalis-nvls-can-the-stock-surprise-this-earnings-season?cid=CS-ZC-FT-225411 Jul 27, 2016 - Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
CVS Health (CVS) Q2 Earnings: What's in the Cards? http://www.zacks.com/stock/news/225408/cvs-health-cvs-q2-earnings-whats-in-the-cards?cid=CS-ZC-FT-225408 Jul 27, 2016 - CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
<<<Page 76>